Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 4
2005 3
2006 7
2007 4
2008 8
2009 6
2010 6
2011 11
2012 9
2013 9
2014 5
2015 4
2016 5
2017 1
2018 5
2019 5
2020 7
2021 4
2022 1
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study.
Meric-Bernstam F, Sweis RF, Kasper S, Hamid O, Bhatia S, Dummer R, Stradella A, Long GV, Spreafico A, Shimizu T, Steeghs N, Luke JJ, McWhirter SM, Müller T, Nair N, Lewis N, Chen X, Bean A, Kattenhorn L, Pelletier M, Sandhu S. Meric-Bernstam F, et al. Among authors: lewis n. Clin Cancer Res. 2023 Jan 4;29(1):110-121. doi: 10.1158/1078-0432.CCR-22-2235. Clin Cancer Res. 2023. PMID: 36282874 Clinical Trial.
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas.
Meric-Bernstam F, Sweis RF, Hodi FS, Messersmith WA, Andtbacka RHI, Ingham M, Lewis N, Chen X, Pelletier M, Chen X, Wu J, McWhirter SM, Müller T, Nair N, Luke JJ. Meric-Bernstam F, et al. Among authors: lewis n. Clin Cancer Res. 2022 Feb 15;28(4):677-688. doi: 10.1158/1078-0432.CCR-21-1963. Clin Cancer Res. 2022. PMID: 34716197 Clinical Trial.
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
Leidner R, Conlon K, McNeel DG, Wang-Gillam A, Gupta S, Wesolowski R, Chaudhari M, Hassounah N, Lee JB, Ho Lee L, O'Keeffe JA, Lewis N, Pavlakis GN, Thompson JA. Leidner R, et al. Among authors: lewis n. J Immunother Cancer. 2023 Oct;11(10):e007725. doi: 10.1136/jitc-2023-007725. J Immunother Cancer. 2023. PMID: 37907221 Free PMC article. Clinical Trial.
Occult primary.
Ettinger DS, Agulnik M, Cristea M, Eaton K, Fidias PM, Gockerman JP, Hameed O, Handorf C, Harris EI, Jacobs CD, Javle M, Khushalani NI, Kvols L, Lenzi R, Lewis NL, Rashid A, Saltz L, Shulman LN, Zager JS, Zhen W. Ettinger DS, et al. Among authors: lewis nl. J Natl Compr Canc Netw. 2008 Nov;6(10):1026-60. doi: 10.6004/jnccn.2008.0078. J Natl Compr Canc Netw. 2008. PMID: 19176200 Review. No abstract available.
Correction: Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas.
Meric-Bernstam F, Sweis RF, Hodi FS, Messersmith WA, Andtbacka RHI, Ingham M, Lewis N, Chen X, Pelletier M, Chen X, Wu J, Dubensky TW, McWhirter SM, Müller T, Nair N, Luke JJ. Meric-Bernstam F, et al. Among authors: lewis n. Clin Cancer Res. 2023 Jun 13;29(12):2336. doi: 10.1158/1078-0432.CCR-23-1170. Clin Cancer Res. 2023. PMID: 37309603 No abstract available.
What implementation interventions increase cancer screening rates? a systematic review.
Brouwers MC, De Vito C, Bahirathan L, Carol A, Carroll JC, Cotterchio M, Dobbins M, Lent B, Levitt C, Lewis N, McGregor SE, Paszat L, Rand C, Wathen N. Brouwers MC, et al. Among authors: lewis n. Implement Sci. 2011 Sep 29;6:111. doi: 10.1186/1748-5908-6-111. Implement Sci. 2011. PMID: 21958556 Free PMC article. Review.
Rehabilitation and medical management of the adult with spina bifida.
Dicianno BE, Kurowski BG, Yang JM, Chancellor MB, Bejjani GK, Fairman AD, Lewis N, Sotirake J. Dicianno BE, et al. Among authors: lewis n. Am J Phys Med Rehabil. 2008 Dec;87(12):1027-50. doi: 10.1097/PHM.0b013e31818de070. Am J Phys Med Rehabil. 2008. PMID: 18923330 Review.
Creating a Stronger Culture of Safety Within US Community Pharmacies.
Lewis NJW, Marwitz KK, Gaither CA, Haugtvedt CL, Selkow L, Sinha S. Lewis NJW, et al. Jt Comm J Qual Patient Saf. 2023 May;49(5):280-284. doi: 10.1016/j.jcjq.2023.01.012. Epub 2023 Feb 10. Jt Comm J Qual Patient Saf. 2023. PMID: 36907723 No abstract available.
108 results